Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H15N3O |
| Molecular Weight | 265.3098 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(NCCC1=CNC2=C1C=CC=C2)C3=CN=CC=C3
InChI
InChIKey=ZDAZUJBASMCUAK-UHFFFAOYSA-N
InChI=1S/C16H15N3O/c20-16(13-4-3-8-17-10-13)18-9-7-12-11-19-15-6-2-1-5-14(12)15/h1-6,8,10-11,19H,7,9H2,(H,18,20)
| Molecular Formula | C16H15N3O |
| Molecular Weight | 265.3098 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Nicotredole (Tryptamide), similarly to ibuprofen and piroxicam, shows anti-inflammatory and analgesic properties. Tryptamide reversed pyrogen-induced hyperthermia in rats, elicited analgesic effects in rats, but not in mice, prolonged the time of hexobarbital sleep in rats and inhibited locomotor activity in rats and mice. Tryptamide has not elicited side effects on the circulatory system of rats and cats.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095157 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2972998 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Characterization of the binding properties of SIRT2 inhibitors with a N-(3-phenylpropenoyl)-glycine tryptamide backbone. | 2008-09-01 |
|
| Development of a gas-liquid chromatographic method for the analysis of fatty acid tryptamides in cocoa products. | 2006-05-03 |
|
| Pharmacokinetics of tryptamide following intravenous administration in rats. | 1991-01-01 |
|
| Pharmacokinetics of tryptamide following oral and intraperitoneal administration in rats. | 1990 |
|
| Influence of N-3-pyridoyltryptamine (tryptamide) on fetal development in rats and mice. | 1987-11-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1837608
Curator's Comment: Nicotredole was also administered po or ip at a dose 25 mg/kg to rats
https://www.ncbi.nlm.nih.gov/pubmed/12959253
Rats: Plasma and tissue levels of N-3-pyridoyl-tryptamine (Nicotredole) vs. time were determined in rats following iv administration of various doses: 6.25, 12.5, 25.0 and 37.5 mg/kg.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2972998
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:23:32 GMT 2025
by
admin
on
Mon Mar 31 18:23:32 GMT 2025
|
| Record UNII |
0F1T12OCLX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C74332
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
SUB09248MIG
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
29876-14-0
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
138472
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
100000084399
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
DTXSID8045698
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
CHEMBL1491339
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
7301
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
0F1T12OCLX
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY | |||
|
65768
Created by
admin on Mon Mar 31 18:23:32 GMT 2025 , Edited by admin on Mon Mar 31 18:23:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |